József Tóvári (Jozsef Tovari)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Multidrug Resistant

Lower Urinary Tract Symptoms

Top Venues

International journal of molecular sciences

Communications chemistry

ACS chemical biology

Cellular and molecular life sciences : CMLS

This page only lists publications with an associated author ORCID identifier.

Publications

Péter Ábrányi-Balogh, Dávid Bajusz, Zoltán Orgován, Aaron B Keeley, László Petri, Nikolett Péczka, Tibor Viktor Szalai, Gyula Pálfy, Márton Gadanecz, Emma K Grant, Tímea Imre, Tamás Takács, Ivan Ranđelović, Marcell Baranyi, András Marton, Gitta Schlosser, Qirat F Ashraf, Elvin Dominic de Araujo, Tamás Karancsi, László Buday, József Tóvári, András Perczel, Jacob T Bush, György Miklós Keserű
Mapping protein binding sites by photoreactive fragment pharmacophores. Communications chemistry 7 (1) (2024)
Ivan Ranđelović, Kinga Nyíri, Gergely Koppány, Marcell Baranyi, József Tóvári, Attila Kigyós, József Tímár, Beáta G Vértessy, Vince Grolmusz
Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development. International journal of molecular sciences 25 (5) (2024)
Dénes Szepesi Kovács, Bettina Pásztor, Péter Ábrányi-Balogh, László Petri, Tímea Imre, József Simon, Enikő Tátrai, György Várady, József Tóvári, Peter A Szijj, György Miklós Keserű
Site-Selective Antibody Conjugation with Dibromopyrazines. Bioconjugate chemistry (2024)
Nikolett Péczka, Ivan Ranđelović, Zoltán Orgován, Noémi Csorba, Attila Egyed, László Petri, Péter Ábrányi-Balogh, Márton Gadanecz, András Perczel, József Tóvári, Gitta Schlosser, Tamás Takács, Levente M Mihalovits, György G Ferenczy, József Kardos, György Miklós Keserű
Contribution of Noncovalent Recognition and Reactivity to the Optimization of Covalent Inhibitors: A Case Study on KRas G12C . ACS chemical biology (2024)
Péter Ábrányi-Balogh, Dávid Bajusz, Zoltán Orgován, Aaron B Keeley, László Petri, Nikolett Péczka, Tibor Viktor Szalai, Gyula Pálfy, Márton Gadanecz, Emma K Grant, Tímea Imre, Tamás Takács, Ivan Ranđelović, Marcell Baranyi, András Marton, Gitta Schlosser, Qirat F Ashraf, Elvin Dominic de Araujo, Tamás Karancsi, László Buday, József Tóvári, András Perczel, Jacob T Bush, György Miklós Keserű
Mapping protein binding sites by photoreactive fragment pharmacophores. Communications chemistry 7 (1) (2024)
Nikolett Péczka, Ivan Ranđelović, Zoltán Orgován, Noémi Csorba, Attila Egyed, László Petri, Péter Ábrányi-Balogh, Márton Gadanecz, András Perczel, József Tóvári, Gitta Schlosser, Tamás Takács, Levente M Mihalovits, György G Ferenczy, József Kardos, György Miklós Keserű
Contribution of Noncovalent Recognition and Reactivity to the Optimization of Covalent Inhibitors: A Case Study on KRas G12C . ACS chemical biology 19 (8) (2024)
Nikolett Péczka, Ivan Ranđelović, Zoltán Orgován, Noémi Csorba, Attila Egyed, László Petri, Péter Ábrányi-Balogh, Márton Gadanecz, András Perczel, József Tóvári, Gitta Schlosser, Tamás Takács, Levente M Mihalovits, György G Ferenczy, József Kardos, György Miklós Keserű
Contribution of Noncovalent Recognition and Reactivity to the Optimization of Covalent Inhibitors: A Case Study on KRas G12C . ACS chemical biology 19 (8) (2024)
Péter Ábrányi-Balogh, Dávid Bajusz, Zoltán Orgován, Aaron B Keeley, László Petri, Nikolett Péczka, Tibor Viktor Szalai, Gyula Pálfy, Márton Gadanecz, Emma K Grant, Tímea Imre, Tamás Takács, Ivan Ranđelović, Marcell Baranyi, András Marton, Gitta Schlosser, Qirat F Ashraf, Elvin Dominic de Araujo, Tamás Karancsi, László Buday, József Tóvári, András Perczel, Jacob T Bush, György Miklós Keserű
Mapping protein binding sites by photoreactive fragment pharmacophores. Communications chemistry 7 (1) (2024)
Nikolett Péczka, Ivan Ranđelović, Zoltán Orgován, Noémi Csorba, Attila Egyed, László Petri, Péter Ábrányi-Balogh, Márton Gadanecz, András Perczel, József Tóvári, Gitta Schlosser, Tamás Takács, Levente M Mihalovits, György G Ferenczy, József Kardos, György Miklós Keserű
Contribution of Noncovalent Recognition and Reactivity to the Optimization of Covalent Inhibitors: A Case Study on KRas G12C . ACS chemical biology 19 (8) (2024)
Ivan Ranđelović, Kinga Nyíri, Gergely Koppány, Marcell Baranyi, József Tóvári, Attila Kigyós, József Tímár, Beáta G Vértessy, Vince Grolmusz
Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development. International journal of molecular sciences 25 (5) (2024)
Péter Ábrányi-Balogh, Dávid Bajusz, Zoltán Orgován, Aaron B Keeley, László Petri, Nikolett Péczka, Tibor Viktor Szalai, Gyula Pálfy, Márton Gadanecz, Emma K Grant, Tímea Imre, Tamás Takács, Ivan Ranđelović, Marcell Baranyi, András Marton, Gitta Schlosser, Qirat F Ashraf, Elvin Dominic de Araujo, Tamás Karancsi, László Buday, József Tóvári, András Perczel, Jacob T Bush, György Miklós Keserű
Mapping protein binding sites by photoreactive fragment pharmacophores. Communications chemistry 7 (1) (2024)
Ivan Ranđelović, Kinga Nyíri, Gergely Koppány, Marcell Baranyi, József Tóvári, Attila Kigyós, József Tímár, Beáta G Vértessy, Vince Grolmusz
Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development. International journal of molecular sciences 25 (5) (2024)
József Tóvári, Diána Vári-Mező, Sára Eszter Surguta, Andrea Ladányi, Attila Kigyós, Mihály Cserepes
Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets. Cells 12 (14) (2023)
Hargita Hegyesi, Éva Pallinger, Szabina Mecsei, Balázs Hornyák, Csenger Kovácsházi, Gábor B Brenner, Zoltán Giricz, Krisztina Pálóczi, Ágnes Kittel, József Tóvári, Lilla Turiák, Delaram Khamari, Peter Ferdinandy, Edit Irén Buzás
Circulating cardiomyocyte-derived extracellular vesicles reflect cardiac injury during systemic inflammatory response syndrome in mice. Cellular and molecular life sciences : CMLS 79 (2) (2022)
Dominika Rittler, Eszter Molnár, Marcell Baranyi, Tamás Garay, Luca Hegedűs, Clemens Aigner, József Tóvári, József Tímár, Balazs Hegedüs
Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations. International journal of molecular sciences 21 (20) (2020)
Anikó Gaál, Tamás M Garay, Ildikó Horváth, Domokos Mathe, Dávid Szöllősi, Dániel S Veres, Jeremiah Mbuotidem, Tibor Kovacs, József Tóvári, Ralf K Bergmann, Christina Streli, Gergely Szakács, Judith Mihály, Zoltán Varga, Norbert Szoboszlai
Development and In Vivo Application of a Water-Soluble Anticancer Copper Ionophore System Using a Temperature-Sensitive Liposome Formulation. Pharmaceutics 12 (5) (2020)
Mihály Cserepes, Dóra Türk, Szilárd Tóth, Veronika F S Pape, Anikó Gaál, Melinda Gera, Judit E Szabó, Nóra Kucsma, György Várady, Beáta G Vértessy, Christina Streli, Pál T Szabó, József Tóvári, Norbert Szoboszlai, Gergely Szakács
Unshielding Multidrug Resistant Cancer through Selective Iron Depletion of P-Glycoprotein-Expressing Cells. Cancer research 80 (4) (2019)
Dominika Rittler, Marcell Baranyi, Eszter Molnár, Tamás Garay, István Jalsovszky, Imre Károly Varga, Luca Hegedűs, Clemens Aigner, József Tóvári, József Tímár, Balazs Hegedüs
The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb. International journal of molecular sciences 20 (19) (2019)
Andrea Angelo Pierluigi Tripodi, Ivan Ranđelović, Beáta Biri-Kovács, Bálint Szeder, Gábor Mező, József Tóvári
In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery. Pathology oncology research : POR 26 (3) (2019)